Dr. Clifton Huang

Claim this profile

Cook Children's Medical Center

Studies Ulcerative Colitis
Studies Ulcer
6 reported clinical trials
2 drugs studied

Affiliated Hospitals

Image of trial facility.
Cook Children's Medical Center
Image of trial facility.
Cook Children's Hospital

Clinical Trials Clifton Huang is currently running

Image of trial facility.

Mirikizumab

for Ulcerative Colitis

This trial is testing a medication called mirikizumab to see if it can help children with ulcerative colitis or Crohn's disease by reducing inflammation in their digestive tracts.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

ABX464 Maintenance Therapy

for Ulcerative Colitis

This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106. All eligible subjects who have completed either one of the induction studies above mentioned, will be given the opportunity to take part in the present ABX464-107 maintenance study and will be randomized to either a double blind, placebo-controlled part (Part #1) or allocated to ABX464 50mg or 25mg open label treatment arms (Part #2) depending on their clinical response at the end of induction. This study consists of a 44-week treatment phase and a 28-days follow-up period consisting in the End of Study (EOS) visit.
Recruiting1 award Phase 3

More about Clifton Huang

Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Clifton Huang has experience with
  • Mirikizumab
  • ABX464

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Clifton Huang specialize in?
Clifton Huang focuses on Ulcerative Colitis and Ulcer. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Clifton Huang currently recruiting for clinical trials?
Yes, Clifton Huang is currently recruiting for 4 clinical trials in Fort Worth Texas. If you're interested in participating, you should apply.
Are there any treatments that Clifton Huang has studied deeply?
Yes, Clifton Huang has studied treatments such as Mirikizumab, ABX464.
What is the best way to schedule an appointment with Clifton Huang?
Apply for one of the trials that Clifton Huang is conducting.
What is the office address of Clifton Huang?
The office of Clifton Huang is located at: Cook Children's Medical Center, Fort Worth, Texas 76104 United States. This is the address for their practice at the Cook Children's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.